Close Menu

NEW YORK – Singaporean cancer diagnostic firm Biolidics announced Friday it has entered into an agreement to acquire Biomedics Laboratory for up to S$3.7 million ($2.6 million).

Under the deal, Biolidics will pay S$100,000 when the acquisition is completed and can defer the rest of the payment for up to two years. If the company finishes paying in one year, the total cost would be S$3.5 million. Otherwise, the cost of the deal would be S$3.7 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.